{"database": "openregs", "table": "documents", "rows": [["EPA-HQ-OPP-2017-0314-0020", "EPA", "EPA-HQ-OPP-2017-0314", "Alpha methyl mannoside: Summary of the Hazard and Science Policy Council (HASPOC) Meeting on August 10, 2017: Recommendations on the need for 90-Day Dermal, 90-Day Inhalation, and Prenatal Developmental Toxicity studies.", "Supporting & Related Material", "Report", "2018-02-23T05:00:00Z", 2018, 2, null, null, "2018-02-24T01:45:44Z", null, 0, 0, "0900006482f5a4cd"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["EPA-HQ-OPP-2017-0314-0020"], "units": {}, "query_ms": 8.51049501216039, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}